Big news how successfully we can help gluttons. And what profits this would bring so stock went up. Really nothing to celebrate. Do we want to treat a patient?
Amgen is planning a periodic purge for personnel replacement. May be different than usual dead wood cleansing. This time it will be in 2 stages. First will be some dead wood removal and second, some time later will be embracing the DEI pruning depending how the other pharma companies handle this issue. DEI word may not be used in that process. Later Amgen would have openings announcement, pretending to be a growing company. As usual.
Do not give any presentations. They may pickup the information, use it and offer you nothing. This should become general rule everywhere. If you give presentation, it should be only on your published work repetition, not even literature review since they will ask you for opinion. If you do not have publications to present again, you may either politely decline, or do literature review with comments exactly as published papers. Watch out the stock options and other incentives.
